Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
about
MicroRNAs as Salivary Markers for Periodontal Diseases: A New Diagnostic Approach?New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs as Important Players and Biomarkers in Oral CarcinogenesisThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsThe role of microRNA in head and neck cancer: current knowledge and perspectivesSalivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances.microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathwayGenomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.Noninvasive micromarkersEGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma.miR-196a overexpression and miR-196a2 gene polymorphism are prognostic predictors of oral carcinomas.A review of research on salivary biomarkers for oral cancer detection.Difficulties detecting miRNA-203 in human whole saliva by the use of PCR.Salivary extracellular noncoding RNA: emerging biomarkers for molecular diagnostics.Non-coding RNAs in saliva: emerging biomarkers for molecular diagnosticsSalivary MicroRNA in Pancreatic Cancer Patients.Upregulation of miR-372 and -373 associates with lymph node metastasis and poor prognosis of oral carcinomas.A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinomaMicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.Salivary biomarker development using genomic, proteomic and metabolomic approaches.The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.MicroRNAs in Head and Neck CancerA review of expression profiling of circulating microRNAs in men with prostate cancer.Molecular and cellular cues of diet-associated oral carcinogenesis--with an emphasis on areca-nut-induced oral cancer development.MicroRNAs as biomarkers in pituitary tumors.miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids.The emerging landscape of salivary diagnostics.Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.Low p21 level is necessary for the suppressive effects of micoRNA-31 on glioma cell migration and invasion.Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1.Plasma and saliva miR-21 expression in colorectal cancer patients.Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.Looking in the mouth for noninvasive gene expression-based methods to detect oral, oropharyngeal, and systemic cancer.More Accurate Oral Cancer Screening with Fewer Salivary Biomarkers.
P2860
Q26739442-01257A83-A6FB-4EA2-8D67-176ABD6A9446Q26748881-DB8CCF8B-DFC8-4D08-B3F3-822586F6F9B2Q26773183-CC62CA0E-A013-4685-A909-A2C9EFD9587DQ26778591-81E16DC9-6EC9-4DF4-853D-D15A119F5C7FQ26825022-D23606D7-9FE9-4EB8-A13C-B9D4EE70BF17Q26851256-F0ECE67E-F6F1-409D-A6DD-3727983D7190Q33683154-21860674-3385-4A57-8BA5-41E08AFCDEC4Q33792672-3AB68FBD-F61D-48DC-8DA5-AA18F72423ACQ33936552-DB6BAFD3-6DC9-4388-99B4-8F239BD7CDC7Q34111606-5826BCF2-E3CA-4442-8809-377D49B03011Q34208077-475017E7-7B72-40AC-80F2-E9032040A939Q34310702-484A84E5-3E46-49CF-B64C-6B64299BAD4DQ34659915-16F27F98-575D-4031-9DD9-60ED37B768F0Q35373976-F38B1AFE-5850-4861-9033-5623C9C8F3A8Q35394619-F1E707B3-0D75-47F1-88A7-59FB064F708CQ35585721-FD75CD85-0B7A-4419-AC7E-FBF62580754DQ35677442-652395F9-53BA-4200-8228-8297A87508BEQ35685531-E7DCCF0B-CAA1-4691-A8EE-0A4D72C4B04CQ36287854-171630EC-E50A-4259-9790-71C424927AFCQ36603067-30FA7918-78CA-448D-AFB1-062E489C4FF5Q36632967-57A0B5FD-CD91-40C5-8AA1-139B857F6193Q36962563-2E669EBA-8913-4711-9CCF-6166DD4A0757Q37292279-EAB1B55A-5276-44A0-8D07-E99953A62A97Q38011763-E03C6E14-41A0-463D-BBC2-A20F9EA90C60Q38188018-5C50DE4A-7BB7-4D7B-B753-48DCA2A794CDQ38205084-04A296B4-474D-4D78-A5F9-F1B673B3DE66Q38249250-0141C13E-25BA-410B-B3FC-D57FF38E747CQ38264253-729A2DED-FF3F-4AA4-9FAB-C7D035112F9DQ38667953-D0EF155B-EEC0-46BD-9F3E-DF77FD5D3F9DQ38738057-BB4E9620-0AE4-4DE9-9E17-AEE9B1BEED0AQ38755836-2665C12B-C8D5-4A4E-863C-118B8BC57A65Q38800315-48B37FB0-717A-4EBE-8EF3-C4CAA082DBE7Q38815624-0437C9E8-AB97-478C-A9AA-EDFA794E3ECDQ38936321-5D3A442E-BC3B-4DBB-A25F-D6735875A744Q38944423-B8E9F9C4-F542-4A65-BC57-4E188F45604BQ39063655-85924D69-D54B-41F9-B13F-6F9E1F8898B2Q39137443-0691099D-1C18-4AE8-9436-E4BE54C52ABAQ41532176-AEE85930-8A0C-443F-94C5-7C74228DECCAQ42534413-AD0E5852-193B-48F0-81F3-E4AF01FC334CQ44201624-6702A57D-2696-473B-9E7E-298D624EA99C
P2860
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@en
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@nl
type
label
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@en
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@nl
prefLabel
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@en
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
@en
P2093
Cheng-Chieh Yang
Chung-Ji Liu
Hui-Wen Cheng
Kuo-Wei Chang
Shu-Chun Lin
P2860
P304
P356
10.1002/HED.21713
P577
2011-04-15T00:00:00Z